Actively Recruiting
Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study
Led by Sykehuset i Vestfold HF · Updated on 2023-05-15
48
Participants Needed
1
Research Sites
196 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical intervention study is to investigate the effects of exergaming on cognition and other clinical symptoms in outpatient individuals with schizophrenia. The main questions it aims to answer are: Will an exergaming intervention contribute to improved cognition and reduced clinical symptoms, as well as enhanced physical health/self-efficacy/quality of life, in individuals with schizophrenia? Will the gaming component strengthen motivation for a physically more intensive component, so that attendance will be at least as high as in comparable exercise studies despite the current study being implemented in a resource-limited, regular clinical outpatient setting? Participants will be asked to engage in two 45 minutes exergaming sessions with a designated personal trainer for 12 weeks. Results pre- and post intervention will be compared, and comparisons will also be made with a former randomized controlled trial conducted at the same site, in which the currently combined activities were investigated separately (high-intensity interval training and low-intensity video gaming), both yielding positive but different effects.
CONDITIONS
Official Title
Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to give consent
- Understanding and speaking a Scandinavian language
- Diagnosed with schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder, or schizophreniform disorder) according to ICD-10 criteria
You will not qualify if you...
- Diagnosis of intellectual disability
- Diagnosis of neurological disorder
- History of severe head trauma
- Pregnancy
- Chest pain during exercise
- Unstable angina pectoris
- Malignant hypertension
- Uncontrollable arrhythmia
- Recent myocardial infarction
- Acute infection with lymphadenopathy
- Any other medical condition that makes participation unsafe
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
DPS Vestfold, Vestfold Sykehus HF
Tønsberg, Vestfold, Norway, 3120
Actively Recruiting
Research Team
T
Tom Langerud Holmen, PhD
CONTACT
O
Ole Jakob Bredrup, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here